SCHEMBL650044

SCHEMBL650044

CC(C)(C)OC(=O)N1C[C@@H]2CCN(c3ccc(Cl)nc3)C[C@@H]21

nearest known ligand 0.47

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.47
CHRNB4 P30926 2/20 0.47
CHRNA3 P32297 2/20 0.47
CHRNA4 P43681 2/20 0.47
GPR119 Q8TDV5 12/20 0.47
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
RET P07949 1/20 0.41
USP30 Q70CQ3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL650326 0.93 NR1H2 (0.46) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL652419 0.93 NR1H2 (0.46) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL650823 0.91 CHRNB4 (0.45) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL650968 0.91 CHRNB4 (0.45) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL653780 0.89 NR1H2 (0.48) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL653782 0.89 NR1H2 (0.48) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL653781 0.89 NR1H2 (0.48) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL3585569 0.83 CHRNB2 (0.54) CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL3572939 0.83 CHRNB2 (0.54) CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL3585567 0.83 CHRNB2 (0.54) CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2298775-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-23 EP disclosed
EP-2295437-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-16 EP disclosed